AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Sep 3, 2015
29828_dirs_2015-09-03_b815502b-969e-446b-a1db-3746c7ee5d70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-09-02
Reporting Person: Washington Robin L (EVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-02 | Common Stock | S | 3000 | $101.7537 | Disposed | 97546 | Indirect |
| 2015-09-02 | Common Stock | S | 3150 | $102.5954 | Disposed | 94396 | Indirect |
| 2015-09-02 | Common Stock | S | 100 | $103.41 | Disposed | 94296 | Indirect |
Footnotes
F1: The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Sale prices reported for the transactions reported here range from $101.16 to $102.12. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3: Sale prices reported for the transactions reported here range from $102.22 to $103.06. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.